532041 Stock Overview
Operates in pharmaceutical and biotechnology sectors in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hindustan Bio Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹10.45 |
| 52 Week High | ₹13.47 |
| 52 Week Low | ₹6.86 |
| Beta | -0.21 |
| 11 Month Change | 22.94% |
| 3 Month Change | 34.49% |
| 1 Year Change | -6.95% |
| 33 Year Change | 181.67% |
| 5 Year Change | 228.62% |
| Change since IPO | 5,125.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532041 | IN Biotechs | IN Market | |
|---|---|---|---|
| 7D | -5.6% | 1.6% | -0.8% |
| 1Y | -6.9% | 40.6% | 34.0% |
Return vs Industry: 532041 underperformed the Indian Biotechs industry which returned 40.6% over the past year.
Return vs Market: 532041 underperformed the Indian Market which returned 34% over the past year.
Price Volatility
| 532041 volatility | |
|---|---|
| 532041 Average Weekly Movement | 9.5% |
| Biotechs Industry Average Movement | 6.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: 532041's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 532041's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3 | Jampana Venkata Rama Raju | www.hindustanbiosciences.in |
Hindustan Bio Sciences Limited operates in pharmaceutical and biotechnology sectors in India. The company offers recombinant human erythropoietien drug. It also provides products in various forms, including tablets, capsules, drops, externels, and syrups.
Hindustan Bio Sciences Limited Fundamentals Summary
| 532041 fundamental statistics | |
|---|---|
| Market cap | ₹107.12m |
| Earnings (TTM) | ₹2.62m |
| Revenue (TTM) | ₹14.78m |
40.9x
P/E Ratio7.2x
P/S RatioIs 532041 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532041 income statement (TTM) | |
|---|---|
| Revenue | ₹14.78m |
| Cost of Revenue | ₹9.00m |
| Gross Profit | ₹5.79m |
| Other Expenses | ₹3.17m |
| Earnings | ₹2.62m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.26 |
| Gross Margin | 39.14% |
| Net Profit Margin | 17.71% |
| Debt/Equity Ratio | 317.9% |
How did 532041 perform over the long term?
See historical performance and comparison